Access
To read this story in full you will need to login or make a payment (see right).
Letter
Nature 453, 1122-1126 (19 June 2008) | doi:10.1038/nature06939; Received 3 March 2008; Accepted 1 April 2008; Published online 21 May 2008
Open Innovation Challenges
-
Methods to Analyze Consumer Emotions
The Seeker is looking for methods to analyze consumer emotions. This Challenge requires only a writ...
-
Novel Approaches to Protecting Maize from Insect Damage
The Seeker is looking for novel approaches to protecting maize from insect damage. This Challenge re...
nature jobs
Laboratory Technician (Pharmaceutical Analysis & Quality Control)
- Alliance Institute of Advanced Pharmacy and Health Sciences
- Hyderabad 500038 India
Senior Manager-Pharma / CRO-Strategic Sourcing
- Varda Biotech
- Mumbai India
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Stephanie C. Eisenbarth1,2, Oscar R. Colegio1,3, William O'Connor1, Fayyaz S. Sutterwala1,5 & Richard A. Flavell1,4
- Department of Immunobiology,
- Department of Laboratory Medicine,
- Department of Dermatology, and,
- Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, Connecticut 06520, USA
- Inflammation Program, Department of Medicine, University of Iowa, Iowa City, Iowa 52241, USA
Correspondence to: Richard A. Flavell1,4 Correspondence and requests for materials should be addressed to R.A.F. (Email: richard.flavell@yale.edu).
Abstract
Aluminium adjuvants, typically referred to as 'alum', are the most commonly used adjuvants in human and animal vaccines worldwide, yet the mechanism underlying the stimulation of the immune system by alum remains unknown. Toll-like receptors are critical in sensing infections and are therefore common targets of various adjuvants used in immunological studies. Although alum is known to induce the production of proinflammatory cytokines in vitro, it has been repeatedly demonstrated that alum does not require intact Toll-like receptor signalling to activate the immune system1, 2. Here we show that aluminium adjuvants activate an intracellular innate immune response system called the Nalp3 (also known as cryopyrin, CIAS1 or NLRP3) inflammasome. Production of the pro-inflammatory cytokines interleukin-1
and interleukin-18 by macrophages in response to alum in vitro required intact inflammasome signalling. Furthermore, in vivo, mice deficient in Nalp3, ASC (apoptosis-associated speck-like protein containing a caspase recruitment domain) or caspase-1 failed to mount a significant antibody response to an antigen administered with aluminium adjuvants, whereas the response to complete Freund's adjuvant remained intact. We identify the Nalp3 inflammasome as a crucial element in the adjuvant effect of aluminium adjuvants; in addition, we show that the innate inflammasome pathway can direct a humoral adaptive immune response. This is likely to affect how we design effective, but safe, adjuvants in the future.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
NLRs and the dangers of pollution and agingNature Immunology News and Views (01 Aug 2008)
Research HighlightsNature Immunology News and Views (01 Jul 2004)
RESEARCH
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilizationNature Immunology Article (01 Aug 2008)
The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune responseNature Letters to Editor (06 Mar 2008)
See all 32 matches for Research
